Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.13.80) ((S)-limonene 6-monooxygenase) (EC 1.14.13.48) ((S)-limonene 7-monooxygenase) (EC 1.14.13.49) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)

 CP2C9_HUMAN             Reviewed;         490 AA.
P11712; P11713; Q16756; Q16872; Q5VX92; Q6IRV8; Q8WW80;
01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
30-MAY-2000, sequence version 3.
25-OCT-2017, entry version 200.
RecName: Full=Cytochrome P450 2C9;
EC=1.14.13.- {ECO:0000305|PubMed:3243766};
AltName: Full=(R)-limonene 6-monooxygenase;
EC=1.14.13.80 {ECO:0000269|PubMed:11950794};
AltName: Full=(S)-limonene 6-monooxygenase;
EC=1.14.13.48 {ECO:0000269|PubMed:11950794};
AltName: Full=(S)-limonene 7-monooxygenase;
EC=1.14.13.49 {ECO:0000269|PubMed:11950794};
AltName: Full=CYPIIC9;
AltName: Full=Cholesterol 25-hydroxylase {ECO:0000303|PubMed:3079764};
EC=1.14.99.38 {ECO:0000269|PubMed:21576599};
AltName: Full=Cytochrome P-450MP;
AltName: Full=Cytochrome P450 MP-4;
AltName: Full=Cytochrome P450 MP-8;
AltName: Full=Cytochrome P450 PB-1;
AltName: Full=S-mephenytoin 4-hydroxylase {ECO:0000303|PubMed:3079764};
Name=CYP2C9; Synonyms=CYP2C10;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT CYS-144.
PubMed=2827463;
Meehan R.R., Gosden J.R., Rout D., Hastie N.D., Friedberg T.,
Adesnik M., Buckland R., van Heyningen V., Fletcher J.M., Spurr N.K.,
Sweeney J., Wolf C.R.;
"Human cytochrome P-450 PB-1: a multigene family involved in
mephenytoin and steroid oxidations that maps to chromosome 10.";
Am. J. Hum. Genet. 42:26-37(1988).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT CYS-144.
PubMed=3697070; DOI=10.1093/nar/15.23.10053;
Kimura S., Pastewka J., Gelboin H.V., Gonzalez F.J.;
"cDNA and amino acid sequences of two members of the human P450IIC
gene subfamily.";
Nucleic Acids Res. 15:10053-10054(1987).
[3]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS CYS-144; HIS-150;
ARG-251; GLY-272; LEU-359 AND SER-489.
NIEHS SNPs program;
Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Mammary gland;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=15164054; DOI=10.1038/nature02462;
Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
"The DNA sequence and comparative analysis of human chromosome 10.";
Nature 429:375-381(2004).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
CYS-144.
TISSUE=Liver;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[8]
NUCLEOTIDE SEQUENCE [MRNA] OF 4-490 (ISOFORM 1).
TISSUE=Liver;
PubMed=2963808; DOI=10.1093/oxfordjournals.jbchem.a122145;
Yasumori T., Kawano S., Nagata K., Shimada M., Yamazoe Y., Kato R.;
"Nucleotide sequence of a human liver cytochrome P-450 related to the
rat male specific form.";
J. Biochem. 102:1075-1082(1987).
[9]
NUCLEOTIDE SEQUENCE [MRNA] OF 6-490 (ISOFORM 1), AND VARIANTS CYS-358
AND ASP-417.
TISSUE=Liver;
PubMed=3032244; DOI=10.1021/bi00378a016;
Umbenhauer D.R., Martin M.V., Lloyd R.S., Guengerich F.P.;
"Cloning and sequence determination of a complementary DNA related to
human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase.";
Biochemistry 26:1094-1099(1987).
[10]
NUCLEOTIDE SEQUENCE [MRNA] OF 6-490 (ISOFORM 1), AND VARIANTS CYS-358
AND ASP-417.
PubMed=3196692; DOI=10.1021/bi00418a039;
Ged C., Umbenhauer D.R., Bellew T.M., Bork R.W., Srivastava P.K.,
Shinriki N., Lloyd R.S., Guengerich F.P.;
"Characterization of cDNAs, mRNAs, and proteins related to human liver
microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase.";
Biochemistry 27:6929-6940(1988).
[11]
NUCLEOTIDE SEQUENCE [MRNA] OF 14-490 (ISOFORM 1).
PubMed=1445376;
Ohgiya S., Komori M., Ohi H., Shiramatsu K., Shinriki N., Kamataki T.;
"Six-base deletion occurring in messages of human cytochrome P-450 in
the CYP2C subfamily results in reduction of tolbutamide hydroxylase
activity.";
Biochem. Int. 27:1073-1081(1992).
[12]
PROTEIN SEQUENCE OF 1-29, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL
PROPERTIES, AND CHARACTERIZATION.
PubMed=3079764;
Shimada T., Misono K.S., Guengerich F.P.;
"Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a
prototype of genetic polymorphism in oxidative drug metabolism.
Purification and characterization of two similar forms involved in the
reaction.";
J. Biol. Chem. 261:909-921(1986).
[13]
PROTEIN SEQUENCE OF 1-25, AND CATALYTIC ACTIVITY.
PubMed=3243766;
Komori M., Hashizume T., Ohi H., Miura T., Kitada M., Nagashima K.,
Kamataki T.;
"Cytochrome P-450 in human liver microsomes: high-performance liquid
chromatographic isolation of three forms and their characterization.";
J. Biochem. 104:912-916(1988).
[14]
PARTIAL PROTEIN SEQUENCE.
PubMed=1857342;
Srivastava P.K., Yun C.H., Beaune P.H., Ged C., Guengerich F.P.;
"Separation of human liver microsomal tolbutamide hydroxylase and (S)-
mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.";
Mol. Pharmacol. 40:69-79(1991).
[15]
PROTEIN SEQUENCE OF 1-9; 21-157; 169-249; 264-424; 426-476 AND
484-487.
PubMed=8809086; DOI=10.1006/abbi.1996.0414;
Haining R.L., Hunter A.P., Veronese M.E., Trager W.F., Rettie A.E.;
"Allelic variants of human cytochrome P450 2C9: baculovirus-mediated
expression, purification, structural characterization, substrate
stereoselectivity, and prochiral selectivity of the wild-type and
I359L mutant forms.";
Arch. Biochem. Biophys. 333:447-458(1996).
[16]
PROTEIN SEQUENCE OF 1-20.
PubMed=8215449; DOI=10.1006/abbi.1993.1536;
Sandhu P., Baba T., Guengerich F.P.;
"Expression of modified cytochrome P450 2C10 (2C9) in Escherichia
coli, purification, and reconstitution of catalytic activity.";
Arch. Biochem. Biophys. 306:443-450(1993).
[17]
CATALYTIC ACTIVITY.
PubMed=11950794; DOI=10.1124/dmd.30.5.602;
Miyazawa M., Shindo M., Shimada T.;
"Metabolism of (+)- and (-)-limonenes to respective carveols and
perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes.";
Drug Metab. Dispos. 30:602-607(2002).
[18]
CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
PubMed=21576599; DOI=10.1194/jlr.M014084;
Honda A., Miyazaki T., Ikegami T., Iwamoto J., Maeda T., Hirayama T.,
Saito Y., Teramoto T., Matsuzaki Y.;
"Cholesterol 25-hydroxylation activity of CYP3A.";
J. Lipid Res. 52:1509-1516(2011).
[19]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Liver;
PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
Wang L., Ye M., Zou H.;
"An enzyme assisted RP-RPLC approach for in-depth analysis of human
liver phosphoproteome.";
J. Proteomics 96:253-262(2014).
[20]
X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 30-490.
PubMed=12861225; DOI=10.1038/nature01862;
Williams P.A., Cosme J., Ward A., Angove H.C., Matak-Vinkovic D.,
Jhoti H.;
"Crystal structure of human cytochrome P450 2C9 with bound warfarin.";
Nature 424:464-468(2003).
[21]
VARIANTS CYP2C9*2 CYS-144 AND CYP2C9*3 LEU-359.
PubMed=8946475;
Stubbins M.J., Harries L.W., Smith G., Tarbit M.H., Wolf C.R.;
"Genetic analysis of the human cytochrome P450 CYP2C9 locus.";
Pharmacogenetics 6:429-439(1996).
[22]
VARIANTS CYP2C9*2 CYS-144; CYS-358; CYP2C9*3 LEU-359 AND ASP-417.
PubMed=9110362;
Bhasker C.R., Miners J.O., Coulter S., Birkett D.J.;
"Allelic and functional variability of cytochrome P4502C9.";
Pharmacogenetics 7:51-58(1997).
[23]
VARIANT CYP2C9*4 THR-359.
PubMed=10739176; DOI=10.1097/00008571-200002000-00011;
Imai J., Ieiri I., Mamiya K., Miyahara S., Furuumi H., Nanba E.,
Yamane M., Fukumaki Y., Ninomiya H., Tashiro N., Otsubo K.,
Higuchi S.;
"Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese
epileptic patients: genetic analysis of the CYP2C9 locus.";
Pharmacogenetics 10:85-89(2000).
[24]
VARIANT CYP2C9*5 GLU-360.
PubMed=11455026;
Dickmann L.J., Rettie A.E., Kneller M.B., Kim R.B., Wood A.J.,
Stein C.M., Wilkinson G.R., Schwarz U.I.;
"Identification and functional characterization of a new CYP2C9
variant (CYP2C9*5) expressed among African Americans.";
Mol. Pharmacol. 60:382-387(2001).
[25]
VARIANT CYP2C9*11 TRP-335.
PubMed=11926893; DOI=10.1001/jama.287.13.1690;
Higashi M.K., Veenstra D.L., Kondo L.M., Wittkowsky A.K.,
Srinouanprachanh S.L., Farin F.M., Rettie A.E.;
"Association between CYP2C9 genetic variants and anticoagulation-
related outcomes during warfarin therapy.";
JAMA 287:1690-1698(2002).
[26]
VARIANTS CYS-144; HIS-150; ARG-251; TRP-335; LEU-359; GLU-360 AND
PRO-413.
PubMed=15469410; DOI=10.1517/14622416.5.7.895;
Solus J.F., Arietta B.J., Harris J.R., Sexton D.P., Steward J.Q.,
McMunn C., Ihrie P., Mehall J.M., Edwards T.L., Dawson E.P.;
"Genetic variation in eleven phase I drug metabolism genes in an
ethnically diverse population.";
Pharmacogenomics 5:895-931(2004).
[27]
VARIANT LEU-125.
PubMed=21451434; DOI=10.1097/FPC.0b013e328344c340;
Ciccacci C., Falconi M., Paolillo N., Oteri F., Forte V., Novelli G.,
Desideri A., Borgiani P.;
"Characterization of a novel CYP2C9 gene mutation and structural
bioinformatic protein analysis in a warfarin hypersensitive patient.";
Pharmacogenet. Genomics 21:344-346(2011).
[28]
VARIANT HIS-204.
PubMed=23582453; DOI=10.1016/j.thromres.2013.03.019;
Nahar R., Dube D., Parakh R., Deb R., Saxena R., Singh T.P.,
Verma I.C.;
"Implication of novel CYP2C9*57 (p.Asn204His) variant in coumarin
hypersensitivity.";
Thromb. Res. 131:535-539(2013).
[29]
VARIANT HIS-125.
PubMed=24956244; DOI=10.2217/pgs.14.47;
Lee Y.M., Eggen J., Soni V., Drozda K., Nutescu E.A., Cavallari L.H.;
"Warfarin dose requirements in a patient with the CYP2C9*14 allele.";
Pharmacogenomics 15:909-914(2014).
[30]
VARIANT PHE-434, CHARACTERIZATION OF VARIANT PHE-434,
BIOPHYSICOCHEMICAL PROPERTIES, AND FUNCTION.
PubMed=25994031; DOI=10.1124/dmd.115.063412;
Dai D.P., Wang S.H., Li C.B., Geng P.W., Cai J., Wang H., Hu G.X.,
Cai J.P.;
"Identification and Functional Assessment of a New CYP2C9 Allelic
Variant CYP2C9*59.";
Drug Metab. Dispos. 43:1246-1249(2015).
-!- FUNCTION: Cytochromes P450 are a group of heme-thiolate
monooxygenases. In liver microsomes, this enzyme is involved in an
NADPH-dependent electron transport pathway. It oxidizes a variety
of structurally unrelated compounds, including steroids, fatty
acids, and xenobiotics (PubMed:25994031). This enzyme contributes
to the wide pharmacokinetics variability of the metabolism of
drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and
losartan (PubMed:25994031). {ECO:0000269|PubMed:25994031}.
-!- CATALYTIC ACTIVITY: (+)-(R)-limonene + NADPH + O(2) = (+)-trans-
carveol + NADP(+) + H(2)O. {ECO:0000269|PubMed:11950794}.
-!- CATALYTIC ACTIVITY: (-)-(S)-limonene + NADPH + O(2) = (-)-trans-
carveol + NADP(+) + H(2)O. {ECO:0000269|PubMed:11950794}.
-!- CATALYTIC ACTIVITY: (-)-(S)-limonene + NADPH + O(2) = (-)-perillyl
alcohol + NADP(+) + H(2)O. {ECO:0000269|PubMed:11950794}.
-!- CATALYTIC ACTIVITY: Cholesterol + AH(2) + O(2) = 25-
hydroxycholesterol + A + H(2)O. {ECO:0000269|PubMed:21576599}.
-!- COFACTOR:
Name=heme; Xref=ChEBI:CHEBI:30413;
-!- BIOPHYSICOCHEMICAL PROPERTIES:
Kinetic parameters:
KM=1.25 mM for S-mephenytoin {ECO:0000269|PubMed:3079764};
KM=46.24 uM for tolbutamide {ECO:0000269|PubMed:25994031};
KM=4.73 uM for diclofenac {ECO:0000269|PubMed:25994031};
KM=1.58 uM for losartan {ECO:0000269|PubMed:25994031};
Vmax=9.22 pmol/min/pmol enzyme with tolbutamide as substrate
{ECO:0000269|PubMed:25994031};
Vmax=17.16 pmol/min/pmol enzyme with diclofenac as substrate
{ECO:0000269|PubMed:25994031};
Vmax=210.30 pmol/min/pmol enzyme with losartan as substrate
{ECO:0000269|PubMed:25994031};
-!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral
membrane protein. Microsome membrane
{ECO:0000269|PubMed:21576599}; Peripheral membrane protein.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=2;
Name=1;
IsoId=P11712-1; Sequence=Displayed;
Name=2;
IsoId=P11712-2; Sequence=VSP_055573, VSP_055574;
Note=No experimental confirmation available.;
-!- INDUCTION: By rifampicin.
-!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
-!- WEB RESOURCE: Name=Cytochrome P450 Allele Nomenclature Committee;
Note=CYP2C9 alleles;
URL="http://www.cypalleles.ki.se/cyp2c9.htm";
-!- WEB RESOURCE: Name=NIEHS-SNPs;
URL="http://egp.gs.washington.edu/data/cyp2c9/";
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AY341248; AAP88931.1; -; Genomic_DNA.
EMBL; AY702706; AAT94065.1; -; Genomic_DNA.
EMBL; AK289420; BAF82109.1; -; mRNA.
EMBL; AL359672; CAH71303.1; -; Genomic_DNA.
EMBL; CH471066; EAW50019.1; -; Genomic_DNA.
EMBL; CH471066; EAW50020.1; -; Genomic_DNA.
EMBL; BC020754; AAH20754.1; -; mRNA.
EMBL; BC070317; AAH70317.1; -; mRNA.
EMBL; BC125054; AAI25055.1; -; mRNA.
EMBL; D00173; BAA00123.1; -; mRNA.
EMBL; M15331; AAA52157.1; -; mRNA.
EMBL; M21939; AAA52158.1; -; mRNA.
EMBL; M21940; AAA52159.1; -; mRNA.
EMBL; S46963; AAB23864.2; ALT_SEQ; mRNA.
CCDS; CCDS7437.1; -. [P11712-1]
PIR; B38462; B38462.
PIR; D28951; D28951.
RefSeq; NP_000762.2; NM_000771.3. [P11712-1]
RefSeq; XP_016871247.1; XM_017015758.1. [P11712-1]
UniGene; Hs.282624; -.
PDB; 1OG2; X-ray; 2.60 A; A/B=30-490.
PDB; 1OG5; X-ray; 2.55 A; A/B=30-490.
PDB; 1R9O; X-ray; 2.00 A; A=18-490.
PDB; 4NZ2; X-ray; 2.45 A; A/B=30-490.
PDB; 5A5I; X-ray; 2.00 A; A=23-489.
PDB; 5A5J; X-ray; 2.90 A; A=23-489.
PDB; 5K7K; X-ray; 2.30 A; A=23-489.
PDB; 5W0C; X-ray; 2.00 A; A=18-489.
PDBsum; 1OG2; -.
PDBsum; 1OG5; -.
PDBsum; 1R9O; -.
PDBsum; 4NZ2; -.
PDBsum; 5A5I; -.
PDBsum; 5A5J; -.
PDBsum; 5K7K; -.
PDBsum; 5W0C; -.
ProteinModelPortal; P11712; -.
SMR; P11712; -.
BioGrid; 107937; 14.
IntAct; P11712; 6.
STRING; 9606.ENSP00000260682; -.
BindingDB; P11712; -.
ChEMBL; CHEMBL3397; -.
DrugBank; DB02507; 4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One.
DrugBank; DB05812; Abiraterone.
DrugBank; DB06736; Aceclofenac.
DrugBank; DB01418; Acenocoumarol.
DrugBank; DB00316; Acetaminophen.
DrugBank; DB00945; Acetylsalicylic acid.
DrugBank; DB06594; Agomelatine.
DrugBank; DB00969; Alosetron.
DrugBank; DB00404; Alprazolam.
DrugBank; DB01424; Aminophenazone.
DrugBank; DB01118; Amiodarone.
DrugBank; DB00321; Amitriptyline.
DrugBank; DB00381; Amlodipine.
DrugBank; DB00613; Amodiaquine.
DrugBank; DB00701; Amprenavir.
DrugBank; DB01217; Anastrozole.
DrugBank; DB01435; Antipyrine.
DrugBank; DB06605; Apixaban.
DrugBank; DB00673; Aprepitant.
DrugBank; DB04557; Arachidonic Acid.
DrugBank; DB01274; Arformoterol.
DrugBank; DB06413; Armodafinil.
DrugBank; DB06697; Artemether.
DrugBank; DB01072; Atazanavir.
DrugBank; DB01076; Atorvastatin.
DrugBank; DB01117; Atovaquone.
DrugBank; DB00972; Azelastine.
DrugBank; DB00307; Bexarotene.
DrugBank; DB01128; Bicalutamide.
DrugBank; DB00188; Bortezomib.
DrugBank; DB00559; Bosentan.
DrugBank; DB00835; Brompheniramine.
DrugBank; DB00921; Buprenorphine.
DrugBank; DB01156; Bupropion.
DrugBank; DB08875; Cabozantinib.
DrugBank; DB00201; Caffeine.
DrugBank; DB00796; Candesartan.
DrugBank; DB01101; Capecitabine.
DrugBank; DB00564; Carbamazepine.
DrugBank; DB00748; Carbinoxamine.
DrugBank; DB01136; Carvedilol.
DrugBank; DB00482; Celecoxib.
DrugBank; DB09063; Ceritinib.
DrugBank; DB00439; Cerivastatin.
DrugBank; DB00446; Chloramphenicol.
DrugBank; DB00672; Chlorpropamide.
DrugBank; DB00169; Cholecalciferol.
DrugBank; DB00501; Cimetidine.
DrugBank; DB00568; Cinnarizine.
DrugBank; DB00604; Cisapride.
DrugBank; DB00515; Cisplatin.
DrugBank; DB04920; Clevidipine.
DrugBank; DB00758; Clopidogrel.
DrugBank; DB00257; Clotrimazole.
DrugBank; DB00363; Clozapine.
DrugBank; DB00907; Cocaine.
DrugBank; DB01394; Colchicine.
DrugBank; DB05219; Crisaborole.
DrugBank; DB01176; Cyclizine.
DrugBank; DB00531; Cyclophosphamide.
DrugBank; DB00091; Cyclosporine.
DrugBank; DB06292; Dapagliflozin.
DrugBank; DB00250; Dapsone.
DrugBank; DB00705; Delavirdine.
DrugBank; DB00967; Desloratadine.
DrugBank; DB01234; Dexamethasone.
DrugBank; DB01191; Dexfenfluramine.
DrugBank; DB04856; Dexloxiglumide.
DrugBank; DB00514; Dextromethorphan.
DrugBank; DB00647; Dextropropoxyphene.
DrugBank; DB00829; Diazepam.
DrugBank; DB00586; Diclofenac.
DrugBank; DB01144; Diclofenamide.
DrugBank; DB00266; Dicoumarol.
DrugBank; DB00255; Diethylstilbestrol.
DrugBank; DB00343; Diltiazem.
DrugBank; DB01075; Diphenhydramine.
DrugBank; DB00822; Disulfiram.
DrugBank; DB00757; Dolasetron.
DrugBank; DB00843; Donepezil.
DrugBank; DB00988; Dopamine.
DrugBank; DB00869; Dorzolamide.
DrugBank; DB01142; Doxepin.
DrugBank; DB00470; Dronabinol.
DrugBank; DB00625; Efavirenz.
DrugBank; DB00216; Eletriptan.
DrugBank; DB08899; Enzalutamide.
DrugBank; DB00668; Epinephrine.
DrugBank; DB01240; Epoprostenol.
DrugBank; DB00876; Eprosartan.
DrugBank; DB00783; Estradiol.
DrugBank; DB00655; Estrone.
DrugBank; DB04574; Estrone sulfate.
DrugBank; DB00402; Eszopiclone.
DrugBank; DB00898; Ethanol.
DrugBank; DB00749; Etodolac.
DrugBank; DB01628; Etoricoxib.
DrugBank; DB06414; Etravirine.
DrugBank; DB01023; Felodipine.
DrugBank; DB01039; Fenofibrate.
DrugBank; DB01195; Flecainide.
DrugBank; DB00322; Floxuridine.
DrugBank; DB00196; Fluconazole.
DrugBank; DB04841; Flunarizine.
DrugBank; DB01544; Flunitrazepam.
DrugBank; DB00544; Fluorouracil.
DrugBank; DB00472; Fluoxetine.
DrugBank; DB00712; Flurbiprofen.
DrugBank; DB01095; Fluvastatin.
DrugBank; DB00176; Fluvoxamine.
DrugBank; DB00983; Formoterol.
DrugBank; DB01320; Fosphenytoin.
DrugBank; DB06741; Gavestinel.
DrugBank; DB00317; Gefitinib.
DrugBank; DB01241; Gemfibrozil.
DrugBank; DB01381; Ginkgo biloba.
DrugBank; DB01120; Gliclazide.
DrugBank; DB00222; Glimepiride.
DrugBank; DB01067; Glipizide.
DrugBank; DB01016; Glyburide.
DrugBank; DB01018; Guanfacine.
DrugBank; DB00502; Haloperidol.
DrugBank; DB01159; Halothane.
DrugBank; DB03317; Heme C.
DrugBank; DB01355; Hexobarbital.
DrugBank; DB05381; Histamine.
DrugBank; DB00062; Human Serum Albumin.
DrugBank; DB00327; Hydromorphone.
DrugBank; DB01050; Ibuprofen.
DrugBank; DB01177; Idarubicin.
DrugBank; DB01181; Ifosfamide.
DrugBank; DB00619; Imatinib.
DrugBank; DB00224; Indinavir.
DrugBank; DB00328; Indomethacin.
DrugBank; DB01029; Irbesartan.
DrugBank; DB00951; Isoniazid.
DrugBank; DB09570; Ixazomib.
DrugBank; DB01221; Ketamine.
DrugBank; DB06738; Ketobemidone.
DrugBank; DB01026; Ketoconazole.
DrugBank; DB01009; Ketoprofen.
DrugBank; DB00448; Lansoprazole.
DrugBank; DB01097; Leflunomide.
DrugBank; DB11560; Lesinurad.
DrugBank; DB04725; Licofelone.
DrugBank; DB00281; Lidocaine.
DrugBank; DB01601; Lopinavir.
DrugBank; DB00455; Loratadine.
DrugBank; DB06725; Lornoxicam.
DrugBank; DB00678; Losartan.
DrugBank; DB00227; Lovastatin.
DrugBank; DB09280; Lumacaftor.
DrugBank; DB01283; Lumiracoxib.
DrugBank; DB00603; Medroxyprogesterone acetate.
DrugBank; DB00784; Mefenamic acid.
DrugBank; DB01065; Melatonin.
DrugBank; DB00814; Meloxicam.
DrugBank; DB00532; Mephenytoin.
DrugBank; DB01357; Mestranol.
DrugBank; DB00333; Methadone.
DrugBank; DB00703; Methazolamide.
DrugBank; DB00763; Methimazole.
DrugBank; DB01028; Methoxyflurane.
DrugBank; DB00916; Metronidazole.
DrugBank; DB01110; Miconazole.
DrugBank; DB00370; Mirtazapine.
DrugBank; DB01171; Moclobemide.
DrugBank; DB00745; Modafinil.
DrugBank; DB00471; Montelukast.
DrugBank; DB11605; Myrrh.
DrugBank; DB00788; Naproxen.
DrugBank; DB00731; Nateglinide.
DrugBank; DB00220; Nelfinavir.
DrugBank; DB09048; Netupitant.
DrugBank; DB00238; Nevirapine.
DrugBank; DB00622; Nicardipine.
DrugBank; DB06803; Niclosamide.
DrugBank; DB00184; Nicotine.
DrugBank; DB01115; Nifedipine.
DrugBank; DB04868; Nilotinib.
DrugBank; DB00665; Nilutamide.
DrugBank; DB06712; Nilvadipine.
DrugBank; DB00540; Nortriptyline.
DrugBank; DB00334; Olanzapine.
DrugBank; DB09080; Olodaterol.
DrugBank; DB00338; Omeprazole.
DrugBank; DB00904; Ondansetron.
DrugBank; DB04938; Ospemifene.
DrugBank; DB00991; Oxaprozin.
DrugBank; DB01229; Paclitaxel.
DrugBank; DB00213; Pantoprazole.
DrugBank; DB00617; Paramethadione.
DrugBank; DB08439; Parecoxib.
DrugBank; DB00715; Paroxetine.
DrugBank; DB00850; Perphenazine.
DrugBank; DB03783; Phenacetin.
DrugBank; DB01174; Phenobarbital.
DrugBank; DB00946; Phenprocoumon.
DrugBank; DB00191; Phentermine.
DrugBank; DB00812; Phenylbutazone.
DrugBank; DB00252; Phenytoin.
DrugBank; DB01132; Pioglitazone.
DrugBank; DB00554; Piroxicam.
DrugBank; DB08860; Pitavastatin.
DrugBank; DB01411; Pranlukast.
DrugBank; DB06209; Prasugrel.
DrugBank; DB00175; Pravastatin.
DrugBank; DB00794; Primidone.
DrugBank; DB01032; Probenecid.
DrugBank; DB00396; Progesterone.
DrugBank; DB01131; Proguanil.
DrugBank; DB00420; Promazine.
DrugBank; DB01069; Promethazine.
DrugBank; DB01182; Propafenone.
DrugBank; DB00818; Propofol.
DrugBank; DB09396; Propoxyphene napsylate.
DrugBank; DB00205; Pyrimethamine.
DrugBank; DB01589; Quazepam.
DrugBank; DB00908; Quinidine.
DrugBank; DB00468; Quinine.
DrugBank; DB01129; Rabeprazole.
DrugBank; DB08896; Regorafenib.
DrugBank; DB01045; Rifampicin.
DrugBank; DB01201; Rifapentine.
DrugBank; DB00503; Ritonavir.
DrugBank; DB00533; Rofecoxib.
DrugBank; DB00412; Rosiglitazone.
DrugBank; DB01098; Rosuvastatin.
DrugBank; DB01698; Rutin.
DrugBank; DB00936; Salicylic acid.
DrugBank; DB01232; Saquinavir.
DrugBank; DB00418; Secobarbital.
DrugBank; DB01037; Selegiline.
DrugBank; DB01104; Sertraline.
DrugBank; DB00203; Sildenafil.
DrugBank; DB00641; Simvastatin.
DrugBank; DB06268; Sitaxentan.
DrugBank; DB00398; Sorafenib.
DrugBank; DB06820; Sulconazole.
DrugBank; DB00359; Sulfadiazine.
DrugBank; DB06150; Sulfadimethoxine.
DrugBank; DB00576; Sulfamethizole.
DrugBank; DB01015; Sulfamethoxazole.
DrugBank; DB08798; Sulfamoxole.
DrugBank; DB00259; Sulfanilamide.
DrugBank; DB06729; Sulfaphenazole.
DrugBank; DB00891; Sulfapyridine.
DrugBank; DB01138; Sulfinpyrazone.
DrugBank; DB00263; Sulfisoxazole.
DrugBank; DB00870; Suprofen.
DrugBank; DB00675; Tamoxifen.
DrugBank; DB06204; Tapentadol.
DrugBank; DB01079; Tegaserod.
DrugBank; DB00231; Temazepam.
DrugBank; DB00444; Teniposide.
DrugBank; DB00469; Tenoxicam.
DrugBank; DB00857; Terbinafine.
DrugBank; DB00342; Terfenadine.
DrugBank; DB00624; Testosterone.
DrugBank; DB01041; Thalidomide.
DrugBank; DB00277; Theophylline.
DrugBank; DB01154; Thiamylal.
DrugBank; DB00679; Thioridazine.
DrugBank; DB08816; Ticagrelor.
DrugBank; DB00208; Ticlopidine.
DrugBank; DB04831; Ticrynafen.
DrugBank; DB01007; Tioconazole.
DrugBank; DB01124; Tolbutamide.
DrugBank; DB00323; Tolcapone.
DrugBank; DB01036; Tolterodine.
DrugBank; DB00214; Torasemide.
DrugBank; DB05109; Trabectedin.
DrugBank; DB00752; Tranylcypromine.
DrugBank; DB00374; Treprostinil.
DrugBank; DB00755; Tretinoin.
DrugBank; DB00897; Triazolam.
DrugBank; DB00347; Trimethadione.
DrugBank; DB00440; Trimethoprim.
DrugBank; DB00726; Trimipramine.
DrugBank; DB00197; Troglitazone.
DrugBank; DB01361; Troleandomycin.
DrugBank; DB00580; Valdecoxib.
DrugBank; DB00313; Valproic Acid.
DrugBank; DB00177; Valsartan.
DrugBank; DB00285; Venlafaxine.
DrugBank; DB00661; Verapamil.
DrugBank; DB08828; Vismodegib.
DrugBank; DB00582; Voriconazole.
DrugBank; DB09068; Vortioxetine.
DrugBank; DB00682; Warfarin.
DrugBank; DB04898; Ximelagatran.
DrugBank; DB00549; Zafirlukast.
DrugBank; DB00943; Zalcitabine.
DrugBank; DB06737; Zaltoprofen.
DrugBank; DB00495; Zidovudine.
DrugBank; DB00744; Zileuton.
DrugBank; DB00425; Zolpidem.
DrugBank; DB01198; Zopiclone.
GuidetoPHARMACOLOGY; 1326; -.
SwissLipids; SLP:000001203; -.
iPTMnet; P11712; -.
PhosphoSitePlus; P11712; -.
BioMuta; CYP2C9; -.
DMDM; 6686268; -.
EPD; P11712; -.
PaxDb; P11712; -.
PeptideAtlas; P11712; -.
PRIDE; P11712; -.
Ensembl; ENST00000260682; ENSP00000260682; ENSG00000138109. [P11712-1]
GeneID; 1559; -.
KEGG; hsa:1559; -.
CTD; 1559; -.
DisGeNET; 1559; -.
EuPathDB; HostDB:ENSG00000138109.9; -.
GeneCards; CYP2C9; -.
HGNC; HGNC:2623; CYP2C9.
HPA; CAB016123; -.
HPA; HPA015066; -.
MalaCards; CYP2C9; -.
MIM; 601130; gene.
neXtProt; NX_P11712; -.
OpenTargets; ENSG00000138109; -.
Orphanet; 413681; Oral antidiabetic drugs toxicity or dose selection.
Orphanet; 413674; Vitamin K antagonists toxicity or dose selection.
PharmGKB; PA126; -.
eggNOG; KOG0156; Eukaryota.
eggNOG; COG2124; LUCA.
GeneTree; ENSGT00880000137861; -.
HOGENOM; HOG000036992; -.
HOVERGEN; HBG015789; -.
InParanoid; P11712; -.
KO; K17719; -.
OMA; ICNNFSP; -.
OrthoDB; EOG091G0BT8; -.
PhylomeDB; P11712; -.
TreeFam; TF352043; -.
BRENDA; 1.14.99.38; 2681.
Reactome; R-HSA-211981; Xenobiotics.
Reactome; R-HSA-211999; CYP2E1 reactions.
Reactome; R-HSA-2142670; Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET).
Reactome; R-HSA-2142816; Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE).
SABIO-RK; P11712; -.
SIGNOR; P11712; -.
ChiTaRS; CYP2C9; human.
EvolutionaryTrace; P11712; -.
GeneWiki; CYP2C9; -.
GenomeRNAi; 1559; -.
PRO; PR:P11712; -.
Proteomes; UP000005640; Chromosome 10.
Bgee; ENSG00000138109; -.
CleanEx; HS_CYP2C9; -.
ExpressionAtlas; P11712; baseline and differential.
Genevisible; P11712; HS.
GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:UniProtKB.
GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
GO; GO:0052741; F:(R)-limonene 6-monooxygenase activity; IEA:UniProtKB-EC.
GO; GO:0018675; F:(S)-limonene 6-monooxygenase activity; IEA:UniProtKB-EC.
GO; GO:0018676; F:(S)-limonene 7-monooxygenase activity; IEA:UniProtKB-EC.
GO; GO:0008392; F:arachidonic acid epoxygenase activity; IBA:GO_Central.
GO; GO:0034875; F:caffeine oxidase activity; IDA:BHF-UCL.
GO; GO:0001567; F:cholesterol 25-hydroxylase activity; IEA:UniProtKB-EC.
GO; GO:0008144; F:drug binding; IDA:BHF-UCL.
GO; GO:0020037; F:heme binding; IEA:InterPro.
GO; GO:0005506; F:iron ion binding; IEA:InterPro.
GO; GO:0004497; F:monooxygenase activity; IDA:BHF-UCL.
GO; GO:0016491; F:oxidoreductase activity; IDA:BHF-UCL.
GO; GO:0019825; F:oxygen binding; TAS:Reactome.
GO; GO:0008395; F:steroid hydroxylase activity; IMP:BHF-UCL.
GO; GO:0043603; P:cellular amide metabolic process; IDA:BHF-UCL.
GO; GO:0042737; P:drug catabolic process; IMP:BHF-UCL.
GO; GO:0017144; P:drug metabolic process; IDA:BHF-UCL.
GO; GO:0019373; P:epoxygenase P450 pathway; IBA:GO_Central.
GO; GO:0042738; P:exogenous drug catabolic process; IDA:BHF-UCL.
GO; GO:0032787; P:monocarboxylic acid metabolic process; IDA:BHF-UCL.
GO; GO:0016098; P:monoterpenoid metabolic process; IDA:BHF-UCL.
GO; GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome.
GO; GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL.
GO; GO:0070989; P:oxidative demethylation; IDA:BHF-UCL.
GO; GO:0008202; P:steroid metabolic process; IMP:BHF-UCL.
GO; GO:0019627; P:urea metabolic process; IDA:BHF-UCL.
GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
Gene3D; 1.10.630.10; -; 1.
InterPro; IPR001128; Cyt_P450.
InterPro; IPR017972; Cyt_P450_CS.
InterPro; IPR002401; Cyt_P450_E_grp-I.
InterPro; IPR036396; Cyt_P450_sf.
Pfam; PF00067; p450; 1.
PRINTS; PR00463; EP450I.
PRINTS; PR00385; P450.
SUPFAM; SSF48264; SSF48264; 1.
PROSITE; PS00086; CYTOCHROME_P450; 1.
1: Evidence at protein level;
3D-structure; Acetylation; Alternative splicing; Complete proteome;
Direct protein sequencing; Endoplasmic reticulum; Heme; Iron;
Lipid metabolism; Membrane; Metal-binding; Microsome; Monooxygenase;
NADP; Oxidoreductase; Phosphoprotein; Polymorphism;
Reference proteome; Steroid metabolism; Sterol metabolism.
CHAIN 1 490 Cytochrome P450 2C9.
/FTId=PRO_0000051700.
METAL 435 435 Iron (heme axial ligand).
MOD_RES 127 127 Phosphoserine.
{ECO:0000250|UniProtKB:P00176}.
MOD_RES 249 249 N6-acetyllysine.
{ECO:0000250|UniProtKB:Q64458}.
MOD_RES 375 375 N6-acetyllysine.
{ECO:0000250|UniProtKB:Q64458}.
VAR_SEQ 161 162 AS -> GG (in isoform 2).
{ECO:0000303|PubMed:15489334}.
/FTId=VSP_055573.
VAR_SEQ 163 490 Missing (in isoform 2).
{ECO:0000303|PubMed:15489334}.
/FTId=VSP_055574.
VARIANT 19 19 L -> I (in allele CYP2C9*7;
dbSNP:rs67807361).
/FTId=VAR_018862.
VARIANT 125 125 R -> H (in allele CYP2C9*35;
dbSNP:rs72558189).
{ECO:0000269|PubMed:24956244}.
/FTId=VAR_075286.
VARIANT 125 125 R -> L (in allele CYP2C9*14).
{ECO:0000269|PubMed:21451434}.
/FTId=VAR_075287.
VARIANT 144 144 R -> C (in allele CYP2C9*2;
dbSNP:rs1799853).
{ECO:0000269|PubMed:15469410,
ECO:0000269|PubMed:15489334,
ECO:0000269|PubMed:2827463,
ECO:0000269|PubMed:3697070,
ECO:0000269|PubMed:8946475,
ECO:0000269|PubMed:9110362,
ECO:0000269|Ref.3}.
/FTId=VAR_008343.
VARIANT 150 150 R -> H (in allele CYP2C9*8;
dbSNP:rs7900194).
{ECO:0000269|PubMed:15469410,
ECO:0000269|Ref.3}.
/FTId=VAR_018863.
VARIANT 204 204 N -> H (in allele CYP2C9*57).
{ECO:0000269|PubMed:23582453}.
/FTId=VAR_075288.
VARIANT 251 251 H -> R (in allele CYP2C9*9;
dbSNP:rs2256871).
{ECO:0000269|PubMed:15469410,
ECO:0000269|Ref.3}.
/FTId=VAR_018864.
VARIANT 272 272 E -> G (in allele CYP2C9*10;
dbSNP:rs9332130). {ECO:0000269|Ref.3}.
/FTId=VAR_018865.
VARIANT 335 335 R -> W (in allele CYP2C9*11;
dbSNP:rs28371685).
{ECO:0000269|PubMed:11926893,
ECO:0000269|PubMed:15469410}.
/FTId=VAR_018866.
VARIANT 358 358 Y -> C (in dbSNP:rs1057909).
{ECO:0000269|PubMed:3032244,
ECO:0000269|PubMed:3196692,
ECO:0000269|PubMed:9110362}.
/FTId=VAR_008344.
VARIANT 359 359 I -> L (in allele CYP2C9*3; responsible
for the tolbutamide poor metabolizer
phenotype; dbSNP:rs1057910).
{ECO:0000269|PubMed:15469410,
ECO:0000269|PubMed:8946475,
ECO:0000269|PubMed:9110362,
ECO:0000269|Ref.3}.
/FTId=VAR_008345.
VARIANT 359 359 I -> T (in allele CYP2C9*4;
dbSNP:rs56165452).
{ECO:0000269|PubMed:10739176}.
/FTId=VAR_013515.
VARIANT 360 360 D -> E (in allele CYP2C9*5; increases the
K(m) value for substrates tested;
dbSNP:rs28371686).
{ECO:0000269|PubMed:11455026,
ECO:0000269|PubMed:15469410}.
/FTId=VAR_013516.
VARIANT 413 413 L -> P (in dbSNP:rs28371687).
{ECO:0000269|PubMed:15469410}.
/FTId=VAR_024717.
VARIANT 417 417 G -> D. {ECO:0000269|PubMed:3032244,
ECO:0000269|PubMed:3196692,
ECO:0000269|PubMed:9110362}.
/FTId=VAR_008346.
VARIANT 434 434 I -> F (in allele CYP2C9*59; produces
warfarin hypersensitivity; increases
affinity but highly decreases enzymatic
activity for tolbutamide; no effect on
affinity but decreases enzymatic activity
for diclofenac; decreases affinity and
highly decreases enzymatic activity for
losartan). {ECO:0000269|PubMed:25994031}.
/FTId=VAR_075289.
VARIANT 489 489 P -> S (in allele CYP2C9*12;
dbSNP:rs9332239). {ECO:0000269|Ref.3}.
/FTId=VAR_018867.
CONFLICT 4 4 L -> I (in Ref. 2; no nucleotide entry).
{ECO:0000305}.
CONFLICT 6 6 V -> S (in Ref. 2; no nucleotide entry).
{ECO:0000305}.
CONFLICT 14 14 L -> M (in Ref. 11; AAB23864).
{ECO:0000305}.
CONFLICT 175 175 C -> Y (in Ref. 1; no nucleotide entry).
{ECO:0000305}.
CONFLICT 239 239 F -> L (in Ref. 1; no nucleotide entry).
{ECO:0000305}.
STRAND 33 35 {ECO:0000244|PDB:1R9O}.
TURN 37 39 {ECO:0000244|PDB:4NZ2}.
HELIX 42 45 {ECO:0000244|PDB:4NZ2}.
HELIX 47 61 {ECO:0000244|PDB:1R9O}.
STRAND 63 71 {ECO:0000244|PDB:1R9O}.
STRAND 73 77 {ECO:0000244|PDB:1R9O}.
HELIX 80 87 {ECO:0000244|PDB:1R9O}.
TURN 88 94 {ECO:0000244|PDB:1R9O}.
STRAND 95 97 {ECO:0000244|PDB:5A5J}.
TURN 105 107 {ECO:0000244|PDB:1R9O}.
STRAND 111 114 {ECO:0000244|PDB:5A5I}.
HELIX 117 131 {ECO:0000244|PDB:1R9O}.
STRAND 134 136 {ECO:0000244|PDB:1R9O}.
HELIX 141 157 {ECO:0000244|PDB:1R9O}.
TURN 158 161 {ECO:0000244|PDB:1R9O}.
HELIX 167 183 {ECO:0000244|PDB:1R9O}.
HELIX 192 208 {ECO:0000244|PDB:1R9O}.
HELIX 211 213 {ECO:0000244|PDB:4NZ2}.
HELIX 214 218 {ECO:0000244|PDB:4NZ2}.
HELIX 222 225 {ECO:0000244|PDB:4NZ2}.
TURN 227 229 {ECO:0000244|PDB:5A5J}.
HELIX 230 253 {ECO:0000244|PDB:1R9O}.
HELIX 263 274 {ECO:0000244|PDB:1R9O}.
STRAND 275 277 {ECO:0000244|PDB:4NZ2}.
HELIX 284 315 {ECO:0000244|PDB:1R9O}.
HELIX 317 330 {ECO:0000244|PDB:1R9O}.
STRAND 333 335 {ECO:0000244|PDB:1R9O}.
HELIX 339 344 {ECO:0000244|PDB:1R9O}.
HELIX 346 359 {ECO:0000244|PDB:1R9O}.
STRAND 374 376 {ECO:0000244|PDB:1R9O}.
STRAND 379 381 {ECO:0000244|PDB:1R9O}.
STRAND 386 389 {ECO:0000244|PDB:1R9O}.
HELIX 392 395 {ECO:0000244|PDB:1R9O}.
TURN 398 400 {ECO:0000244|PDB:1R9O}.
STRAND 401 403 {ECO:0000244|PDB:1R9O}.
HELIX 409 412 {ECO:0000244|PDB:1R9O}.
STRAND 415 417 {ECO:0000244|PDB:1OG5}.
HELIX 431 433 {ECO:0000244|PDB:1R9O}.
HELIX 438 455 {ECO:0000244|PDB:1R9O}.
STRAND 456 462 {ECO:0000244|PDB:1R9O}.
HELIX 464 466 {ECO:0000244|PDB:1R9O}.
STRAND 475 477 {ECO:0000244|PDB:1R9O}.
STRAND 485 489 {ECO:0000244|PDB:1R9O}.
SEQUENCE 490 AA; 55628 MW; 4FDFC395303A4E3E CRC64;
MDSLVVLVLC LSCLLLLSLW RQSSGRGKLP PGPTPLPVIG NILQIGIKDI SKSLTNLSKV
YGPVFTLYFG LKPIVVLHGY EAVKEALIDL GEEFSGRGIF PLAERANRGF GIVFSNGKKW
KEIRRFSLMT LRNFGMGKRS IEDRVQEEAR CLVEELRKTK ASPCDPTFIL GCAPCNVICS
IIFHKRFDYK DQQFLNLMEK LNENIKILSS PWIQICNNFS PIIDYFPGTH NKLLKNVAFM
KSYILEKVKE HQESMDMNNP QDFIDCFLMK MEKEKHNQPS EFTIESLENT AVDLFGAGTE
TTSTTLRYAL LLLLKHPEVT AKVQEEIERV IGRNRSPCMQ DRSHMPYTDA VVHEVQRYID
LLPTSLPHAV TCDIKFRNYL IPKGTTILIS LTSVLHDNKE FPNPEMFDPH HFLDEGGNFK
KSKYFMPFSA GKRICVGEAL AGMELFLFLT SILQNFNLKS LVDPKNLDTT PVVNGFASVP
PFYQLCFIPV


Related products :

Catalog number Product name Quantity
EIAAB08921 (R)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase,(S)-limonene 7-monooxygenase,CYP2C10,CYP2C9,CYPIIC9,Cytochrome P450 2C9,Cytochrome P450 MP-4,Cytochrome P450 MP-8,Cytochrome P450 PB-1,Cytochr
EIAAB08929 (R)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase,(S)-limonene 7-monooxygenase,CYP2C19,CYPIIC17,CYPIIC19,Cytochrome P450 2C19,Cytochrome P450-11A,Cytochrome P450-254C,Homo sapiens,Human,Mephen
EIAAB08920 CYP2C8,CYPIIC8,Cytochrome P450 2C8,Cytochrome P450 form 1,Cytochrome P450 IIC2,Cytochrome P450 MP-12,Cytochrome P450 MP-20,Homo sapiens,Human,S-mephenytoin 4-hydroxylase
EIAAB08974 Albendazole monooxygenase,Albendazole sulfoxidase,CYP3A3,CYP3A4,CYPIIIA3,CYPIIIA4,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,Homo sapiens,Hu
E1557h ELISA kit 21-OHase,CYP21,CYP21A2,CYP21B,Cytochrome P450 21,Cytochrome P450 XXI,Cytochrome P-450c21,Cytochrome P450-C21,Cytochrome P450-C21B,Homo sapiens,Human,Steroid 21-hydroxylase 96T
U1557h CLIA 21-OHase,CYP21,CYP21A2,CYP21B,Cytochrome P450 21,Cytochrome P450 XXI,Cytochrome P-450c21,Cytochrome P450-C21,Cytochrome P450-C21B,Homo sapiens,Human,Steroid 21-hydroxylase 96T
E1557h ELISA 21-OHase,CYP21,CYP21A2,CYP21B,Cytochrome P450 21,Cytochrome P450 XXI,Cytochrome P-450c21,Cytochrome P450-C21,Cytochrome P450-C21B,Homo sapiens,Human,Steroid 21-hydroxylase 96T
U0988Rb CLIA 4-nitrophenol 2-hydroxylase,CYP2E,CYP2E1,CYPIIE1,Cytochrome P450 2E1,Cytochrome P450 isozyme 3A,Cytochrome P450 LM3A,Cytochrome P450-ALC,Oryctolagus cuniculus,Rabbit 96T
E0988Rb ELISA kit 4-nitrophenol 2-hydroxylase,CYP2E,CYP2E1,CYPIIE1,Cytochrome P450 2E1,Cytochrome P450 isozyme 3A,Cytochrome P450 LM3A,Cytochrome P450-ALC,Oryctolagus cuniculus,Rabbit 96T
E0988Rb ELISA 4-nitrophenol 2-hydroxylase,CYP2E,CYP2E1,CYPIIE1,Cytochrome P450 2E1,Cytochrome P450 isozyme 3A,Cytochrome P450 LM3A,Cytochrome P450-ALC,Oryctolagus cuniculus,Rabbit 96T
EIAAB08934 Cyp2d1,Cyp2d-1,Cyp2d9,CYPIID1,Cytochrome P450 2D1,Cytochrome P450-CMF1A,Cytochrome P450-DB1,Cytochrome P450-UT-7,Debrisoquine 4-hydroxylase,Rat,Rattus norvegicus
EIAAB08908 Cyp2b10,Cyp2b-10,Cyp2b20,CYPIIB10,CYPIIB20,Cytochrome P450 2B10,Cytochrome P450 2B20,Cytochrome P450 clone PF3_46,Cytochrome P450-16-alpha,Mouse,Mus musculus,P24,Testosterone 16-alpha hydroxylase
E1557m ELISA kit 21-OHase,Cyp21,Cyp21a1,Cyp21a-1,Cytochrome P450 21,Cytochrome P450 XXI,Cytochrome P-450c21,Cytochrome P450-C21,Mouse,Mus musculus,Steroid 21-hydroxylase 96T
E1557m ELISA 21-OHase,Cyp21,Cyp21a1,Cyp21a-1,Cytochrome P450 21,Cytochrome P450 XXI,Cytochrome P-450c21,Cytochrome P450-C21,Mouse,Mus musculus,Steroid 21-hydroxylase 96T
U1557m CLIA 21-OHase,Cyp21,Cyp21a1,Cyp21a-1,Cytochrome P450 21,Cytochrome P450 XXI,Cytochrome P-450c21,Cytochrome P450-C21,Mouse,Mus musculus,Steroid 21-hydroxylase 96T
U1557b CLIA 21-OHase,Bos taurus,Bovine,CYP21,CYP21A1,Cytochrome P450 21,Cytochrome P450 XXI,Cytochrome P-450c21,Cytochrome P450-C21,Steroid 21-hydroxylase 96T
E1557b ELISA kit 21-OHase,Bos taurus,Bovine,CYP21,CYP21A1,Cytochrome P450 21,Cytochrome P450 XXI,Cytochrome P-450c21,Cytochrome P450-C21,Steroid 21-hydroxylase 96T
E1557b ELISA 21-OHase,Bos taurus,Bovine,CYP21,CYP21A1,Cytochrome P450 21,Cytochrome P450 XXI,Cytochrome P-450c21,Cytochrome P450-C21,Steroid 21-hydroxylase 96T
E1557p ELISA 21-OHase,CYP21,CYP21A1,CYP21A3,Cytochrome P450 21,Cytochrome P450 XXI,Cytochrome P-450c21,Cytochrome P450-C21,Pig,Steroid 21-hydroxylase,Sus scrofa 96T
E1557p ELISA kit 21-OHase,CYP21,CYP21A1,CYP21A3,Cytochrome P450 21,Cytochrome P450 XXI,Cytochrome P-450c21,Cytochrome P450-C21,Pig,Steroid 21-hydroxylase,Sus scrofa 96T
U1557p CLIA 21-OHase,CYP21,CYP21A1,CYP21A3,Cytochrome P450 21,Cytochrome P450 XXI,Cytochrome P-450c21,Cytochrome P450-C21,Pig,Steroid 21-hydroxylase,Sus scrofa 96T
E1557r ELISA kit 21-OHase,Cyp21,Cyp21a1,Cytochrome P450 21,Cytochrome P450 XXI,Cytochrome P-450c21,Cytochrome P450-C21,Rat,Rattus norvegicus,Steroid 21-hydroxylase 96T
E1557r ELISA 21-OHase,Cyp21,Cyp21a1,Cytochrome P450 21,Cytochrome P450 XXI,Cytochrome P-450c21,Cytochrome P450-C21,Rat,Rattus norvegicus,Steroid 21-hydroxylase 96T
U1557r CLIA 21-OHase,Cyp21,Cyp21a1,Cytochrome P450 21,Cytochrome P450 XXI,Cytochrome P-450c21,Cytochrome P450-C21,Rat,Rattus norvegicus,Steroid 21-hydroxylase 96T
EIAAB08901 Cyp2b1,Cyp2b-1,CYPIIB1,Cytochrome P450 2B1,Cytochrome P450b,Cytochrome P450-B,Cytochrome P450-LM2,Cytochrome P450-PB1,Cytochrome P450-PB2,Rat,Rattus norvegicus


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur